Evidence map›Paper›PMID 27824554›Full record

ArticleeLife2016

A specific role for serotonin in overcoming effort cost.

Florent Meyniel, Guy M Goodwin, Jf William Deakin, Corinna Klinge, Christine MacFadyen, Holly Milligan, Emma Mullings, Mathias Pessiglione, Raphaël Gaillard

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05866575 (Prediction of the Therapeutic Response in Depression Based on an Early Neuro-computational Modeling Assessment of Motivation), which is not on this map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05866575 narecruitingnot on this mapstarted 2023, after this paper: background citation

Prediction of the Therapeutic Response in Depression Based on an Early Neuro-computational Modeling Assessment of Motivation

TypeinterventionalSponsorCentre Hospitalier St AnneRan2023 to 2026Enrolled136ConditionsMajor Depressive DisorderArmsescitalopram, vortioxetine
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Impaired effort allocation in schizophrenia.Schizophrenia research. Cognition · 2025
    Article
  10. Article
  11. Clustering and drivers of symptoms observed at week six after antidepressant treatment in depressed outpatients.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Florent MeynielMotivation, Brain and Behavior team, Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.ORCID 0000-0002-6992-678X
Guy M GoodwinDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Jf William DeakinNeuroscience and Psychiatry Unit, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-2750-962X
Corinna KlingeDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Christine MacFadyenDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Holly MilliganNeuroscience and Psychiatry Unit, The University of Manchester, Manchester, United Kingdom.
Emma MullingsNeuroscience and Psychiatry Unit, The University of Manchester, Manchester, United Kingdom.
Mathias PessiglioneMotivation, Brain and Behavior team, Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Raphaël GaillardCentre Hospitalier Sainte-Anne, Service de Psychiatrie, Paris, France.
University of Manchester · GBWarneford Hospital · GBCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin is implicated in many aspects of behavioral regulation. Theoretical attempts to unify the multiple roles assigned to serotonin proposed that it regulates the impact of costs, such as delay or punishment, on action selection. Here, we show that serotonin also regulates other types of action costs such as effort. We compared behavioral performance in 58 healthy humans treated during 8 weeks with either placebo or the selective serotonin reuptake inhibitor escitalopram. The task involved trading handgrip force production against monetary benefits. Participants in the escitalopram group produced more effort and thereby achieved a higher payoff. Crucially, our computational analysis showed that this effect was underpinned by a specific reduction of effort cost, and not by any change in the weight of monetary incentives. This specific computational effect sheds new light on the physiological role of serotonin in behavioral regulation and on the clinical effect of drugs for depression. CLINICAL

trial registrationISRCTN75872983.

Indexed as

BehaviorAdultCitalopramFemaleHand StrengthHealthy VolunteersHumansMalePlacebosRewardSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Receptor AgonistsYoung AdultCitalopramPlacebosSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Receptor Agonistscomputational biologydecision-makingeffortescitalopramhumanneurosciencerewardserotoninsystems biology

Identifiers

PMID27824554
PMCPMC5100997
OpenAlexW2547647442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.